Argenx
ARGX
#630
Rank
C$43.83 B
Marketcap
$723.09
Share price
0.76%
Change (1 day)
2.78%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Cash on Hand

Cash on Hand as of June 2024 : C$4.20 B

According to Argenx 's latest financial reports the company has C$4.20 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Argenx - Cash on Hand chart (from 2021 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$2.97 B0.6%
2021-12-31C$2.95 B-4.97%
2020-12-31C$3.11 B42.47%
2019-12-31C$2.18 B116.44%
2018-12-31C$1.00 B55%
2017-12-31C$0.65 B352.8%
2016-12-31C$0.14 B104.97%
2015-12-31C$70.15 M-26.99%
2014-12-31C$96.09 M103.92%
2013-12-31C$47.12 M64.14%
2012-12-31C$28.7 M-28.78%
2011-12-31C$40.31 M189.03%
2010-12-31C$13.94 M